announcements
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
2008
Cytopics - December 2008 edition 18 December 2008
Presentation on JAK2 inhibitors in MPD's 8 December 2008
Appendix 3b 26 November 2008
Results of meeting - 2008 AGM 20 November 2008
Chairman and Managing Director addresses at 2008 AGM 20 November 2008
Cytopia doses first brain cancer patient in Phase lb/II study 17 November 2008
Appendix 3b 30 October 2008
Cytopia Scientific presentations on JAK2 inhibitor program 16 October 2008
Notice of 2008 Annual General Meeting/Proxy Form 13 October 2008
Cytopia commences second phase II study in brain cancer 4 September 2008
Cytopics - August 2008 edition 29 August 2008
JAK2 inhibitors at American Chemical Society meeting 12 August 2008
Cytopia preliminary final report 8 August 2008
Melbourne Analyst Day briefing 31 July 08 31 July 2008
Cytopia appoints Study Chairman for JAK2 clinical trial 29 July 2008
Cytopia strengthens scientific team with US based drug development specialist 10 July 2008
Cytopia to present data on FMS program with anti-cancer potential 18 June 2008
Release of Cytopia abstract for CYT997 at oral presentation at ASCO 16 May 2008
Novel anti-cancer drug development collaboration 8 May 2008
Cytopics - April 2008 edition 21 April 2008
Cytopia presentation on JAK 2 9 April 2008
CYT clinical trial update 28 March 2008
Cytopia nominates JAK2 clinical candidate for myeloproliferative disorders 18 March 2008
Anti-cancer drug CYT997 update 13 March 2008
Cytopia half-year report: clinical development accelerates in 2008 8 February 2008
Appendix 3b8 February 2008
Cytopia JAK2 inhibitor shows potent activity in cells from MPD patients 30 January 2008
